Home > Insider Trading > Filing (0001209191-20-053342)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1699382	Pmv Pharmaceuticals Inc.	PMVP	()	4/A

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1276600	Khaled Nasr	467 First Street, Suite 201 Los Altos CA 94022	No	No	Yes	No
1293171	H Gilbert Kliman	467 First Street, Suite 201 Los Altos CA 94022	No	No	Yes	No
1443898	Interwest Partners X Lp	467 First Street, Suite 201 Los Altos CA 94022	No	No	Yes	No
1460207	Interwest Management Partners X, Llc	467 First Street, Suite 201 Los Altos CA 94022	No	No	Yes	No
1553019	Keval Desai	467 First Street, Suite 201 Los Altos CA 94022	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-09-25	55,555	$18.00	55,555	No	4	P	Direct
Common Stock	Acquisiton	2020-09-29	1,620,101	$0.00	1,675,656	No	4	C	Direct
Common Stock	Acquisiton	2020-09-29	3,488,398	$0.00	5,164,054	No	4	C	Direct
Common Stock	Acquisiton	2020-09-29	1,040,654	$0.00	6,204,708	No	4	C	Direct
Common Stock	Acquisiton	2020-09-29	265,203	$0.00	6,469,911	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series Seed Preferred Stock	Disposition	2020-09-29	1,620,101	$0.00	1,620,101	$0.00
Common Stock	Series A Preferred Stock	Disposition	2020-09-29	3,488,398	$0.00	3,488,398	$0.00
Common Stock	Series B Preferred Stock	Disposition	2020-09-29	1,040,654	$0.00	1,040,654	$0.00
Common Stock	Series C Preferred Stock	Disposition	2020-09-29	265,203	$0.00	265,203	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct

Footnotes

The securities are directly held by InterWest Partners X, LP ("IW10"). InterWest Management Partners X, LLC ("IMP10"), as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. Arnold L. Oronsky and Gilbert H. Kliman are Managing Directors of IMP10, and Khaled A. Nasr and Keal Desai are Venture Members of IMP10. Each of the foregoing persons may be deemed to beneficially own the shares held by IW10, and each foregoing person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date.